Altox

Database / API & reference standards

API & reference standards

Raltegravir

Raltegravir is listed in the API and reference-standard collection under CAS 518048-05-0. Its represented structure has formula C20H21FN6O5 and a calculated molecular weight of 444.42 g/mol.

2D chemical structure

N N O H N N O N H F O H O N O

Chemical identity

Catalog name
Raltegravir
Common name
Raltegravir
Chemical name
N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
CAS
518048-05-0
SMILES
Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1
InChI
InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)
InChIKey
CZFFBEXEKNGXKS-UHFFFAOYSA-N
Associated API
Raltegravir

Record ID: A185fec680ba4

Computed properties

C20H21FN6O5 Molecular formula
444.423 g/molMolecular weight
444.1557 DaMonoisotopic exact mass
152.24 ŲTopological polar surface area
0.9115 Calculated LogP (Wildman–Crippen)
108.2402 cm³/molMolar refractivity (Wildman–Crippen)
8 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight444.42377.77
Calculated LogP (Wildman–Crippen)0.911524.16
Topological polar surface area152.2489.65
Hydrogen-bond acceptors887.87
Hydrogen-bond donors381.39
Rotatable bonds (strict)669.73

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC20H21FN6O5dimensionless
Molecular weight444.423g/mol
Monoisotopic exact mass444.1557Da
Topological polar surface area152.24Ų
Calculated LogP (Wildman–Crippen)0.9115dimensionless
Molar refractivity (Wildman–Crippen)108.2402cm³/mol
Hydrogen-bond acceptors8count
Hydrogen-bond donors3count
Rotatable bonds (strict)6count
Heavy atoms32count
Heteroatoms12count
Rings3count
Aromatic rings3count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles2count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area180.8605Ų
Valence electrons168count
Radical electrons0count
Bertz complexity1,232.2676index
Balaban J1.8777index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Raltegravir

PDE, HBEL and impurity assessment for Raltegravir

For a substance-specific assessment, request a PDE report for Raltegravir or explore HBEL derivation for Raltegravir. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Raltegravir and qualification of impurities related to Raltegravir.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Raltegravir

Explore Altox services and software through the Altox Pharma-Hub.